Cargando…
MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance
SIMPLE SUMMARY: MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. Data on miRNA-103/107 in high grade serous ovarian cancer is scarce. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues and relate them to patients’ clinico...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563310/ https://www.ncbi.nlm.nih.gov/pubmed/32961797 http://dx.doi.org/10.3390/cancers12092680 |
_version_ | 1783595462537773056 |
---|---|
author | Wilczynski, Milosz Kielbik, Michal Senderowska, Daria Krawczyk, Tomasz Szymanska, Bozena Klink, Magdalena Bieńkiewicz, Jan Romanowicz, Hanna Frühauf, Filip Malinowski, Andrzej |
author_facet | Wilczynski, Milosz Kielbik, Michal Senderowska, Daria Krawczyk, Tomasz Szymanska, Bozena Klink, Magdalena Bieńkiewicz, Jan Romanowicz, Hanna Frühauf, Filip Malinowski, Andrzej |
author_sort | Wilczynski, Milosz |
collection | PubMed |
description | SIMPLE SUMMARY: MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. Data on miRNA-103/107 in high grade serous ovarian cancer is scarce. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues and relate them to patients’ clinicopathological data. MiRNA-103/107, DICER expression levels were also evaluated in selected ovarian cancer cell lines. Clinical and prognostic significance of miRNA-103/107 was not confirmed in our study. However, the results of our study support the possible existence of miRNA-103/107- DICER axis in ovarian cancer. ABSTRACT: High levels of miRNA-103/107 are associated with poor outcomes in the case of breast cancer patients. MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. MiRNA-103/107 expression levels have never been related to patients’ clinicopathological data in epithelial ovarian cancer. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues. Expression levels of both miRNAs were related to the clinicopathological features and survival. We also evaluated expression levels of miRNA-103/107 and DICER in selected ovarian cancer cell lines (A2780, A2780cis, SK-OV-3, OVCAR3). We assessed the relative expression of miRNA-103/107 (quantitative reverse transcription-polymerase chain reaction) in fifty archival formalin-fixed paraffin-embedded tissue samples of primary high grade serous ovarian cancer. Then, miRNA-103/107 and DICER expression levels were evaluated in selected ovarian cancer cell lines. Additionally, DICER, N-/E-cadherin protein levels were assessed with the use of western blot. We identified miRNA-107 up-regulation in ovarian cancer in comparison to healthy tissues (p = 0.0005). In the case of miRNA-103, we did not observe statistically significant differences between cancerous and healthy tissues (p = 0.07). We did not find any correlations between miRNA-103/107 expression levels and clinicopathological features. Kaplan–Meier survival (disease-free and overall survival) analysis revealed that both miRNAs could not be considered as prognostic factors. SK-OV-3 cancer cell lines were characterized by high expression of miRNA-103/107, relatively low expression of DICER (western-blot), and relatively high N-cadherin levels in comparison to other ovarian cancer cell lines. Clinical and prognostic significance of miRNA-103/107 was not confirmed in our study. |
format | Online Article Text |
id | pubmed-7563310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75633102020-10-27 MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance Wilczynski, Milosz Kielbik, Michal Senderowska, Daria Krawczyk, Tomasz Szymanska, Bozena Klink, Magdalena Bieńkiewicz, Jan Romanowicz, Hanna Frühauf, Filip Malinowski, Andrzej Cancers (Basel) Article SIMPLE SUMMARY: MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. Data on miRNA-103/107 in high grade serous ovarian cancer is scarce. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues and relate them to patients’ clinicopathological data. MiRNA-103/107, DICER expression levels were also evaluated in selected ovarian cancer cell lines. Clinical and prognostic significance of miRNA-103/107 was not confirmed in our study. However, the results of our study support the possible existence of miRNA-103/107- DICER axis in ovarian cancer. ABSTRACT: High levels of miRNA-103/107 are associated with poor outcomes in the case of breast cancer patients. MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. MiRNA-103/107 expression levels have never been related to patients’ clinicopathological data in epithelial ovarian cancer. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues. Expression levels of both miRNAs were related to the clinicopathological features and survival. We also evaluated expression levels of miRNA-103/107 and DICER in selected ovarian cancer cell lines (A2780, A2780cis, SK-OV-3, OVCAR3). We assessed the relative expression of miRNA-103/107 (quantitative reverse transcription-polymerase chain reaction) in fifty archival formalin-fixed paraffin-embedded tissue samples of primary high grade serous ovarian cancer. Then, miRNA-103/107 and DICER expression levels were evaluated in selected ovarian cancer cell lines. Additionally, DICER, N-/E-cadherin protein levels were assessed with the use of western blot. We identified miRNA-107 up-regulation in ovarian cancer in comparison to healthy tissues (p = 0.0005). In the case of miRNA-103, we did not observe statistically significant differences between cancerous and healthy tissues (p = 0.07). We did not find any correlations between miRNA-103/107 expression levels and clinicopathological features. Kaplan–Meier survival (disease-free and overall survival) analysis revealed that both miRNAs could not be considered as prognostic factors. SK-OV-3 cancer cell lines were characterized by high expression of miRNA-103/107, relatively low expression of DICER (western-blot), and relatively high N-cadherin levels in comparison to other ovarian cancer cell lines. Clinical and prognostic significance of miRNA-103/107 was not confirmed in our study. MDPI 2020-09-19 /pmc/articles/PMC7563310/ /pubmed/32961797 http://dx.doi.org/10.3390/cancers12092680 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wilczynski, Milosz Kielbik, Michal Senderowska, Daria Krawczyk, Tomasz Szymanska, Bozena Klink, Magdalena Bieńkiewicz, Jan Romanowicz, Hanna Frühauf, Filip Malinowski, Andrzej MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance |
title | MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance |
title_full | MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance |
title_fullStr | MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance |
title_full_unstemmed | MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance |
title_short | MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance |
title_sort | mirna-103/107 in primary high-grade serous ovarian cancer and its clinical significance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563310/ https://www.ncbi.nlm.nih.gov/pubmed/32961797 http://dx.doi.org/10.3390/cancers12092680 |
work_keys_str_mv | AT wilczynskimilosz mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance AT kielbikmichal mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance AT senderowskadaria mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance AT krawczyktomasz mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance AT szymanskabozena mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance AT klinkmagdalena mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance AT bienkiewiczjan mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance AT romanowiczhanna mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance AT fruhauffilip mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance AT malinowskiandrzej mirna103107inprimaryhighgradeserousovariancanceranditsclinicalsignificance |